Condition: Aging · Cellular Senescence · Biomarkers / Blood · Sponsor: Fundacion Miguel Servet
Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity. This study aims to establish an intergenerational cohort of centenarians in Navarra (Spain) to investigate the biological, clinical, environmental, and lifestyle factors associated with extreme longevity. By integrating multidimensional data-including clinical assessments, functional and cognitive measures, and biological markers-this study seeks to improve understanding of aging mechanisms and identify potential determinants of healthy aging.
This description comes directly from the study's public registry record.
Nicolás Martínez Velilla, MD and PhD · +34 848 422 287 · nicolas.martinez.velilla@navarra.es
Fabíola Zambom Ferraresi, PhD · +34 848 422 521 · fabiola.zambom.ferraresi@navarra.es
Always discuss trial participation with your own doctor first.
| Navarrabiomed | Pamplona, Navarre, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07707297